Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dubois JMN"'
Autor:
Hengeveld PJ; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands.; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Kolijn PM; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Demmers JAA; Proteomics Center, Erasmus MC, Rotterdam, the Netherlands., Doff W; Proteomics Center, Erasmus MC, Rotterdam, the Netherlands., Dubois JMN; Department of Hematology and Experimental Immunology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, the Netherlands., Rijken M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands., Assmann JLJC; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., van der Straten L; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands.; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Boiten HJ; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Gussinklo KJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands., Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands., Faber LM; Department of Hematology, Red Cross Hospital, Beverwijk, the Netherlands., Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Kater AP; Department of Hematology and Experimental Immunology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Langerak AW; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands.
Publikováno v:
HemaSphere [Hemasphere] 2023 Sep 15; Vol. 7 (10), pp. e951. Date of Electronic Publication: 2023 Sep 15 (Print Publication: 2023).
Autor:
Hengeveld PJ; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., van Bergen CAM; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Quinten E; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Vervoordeldonk MYL; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Ismailzada W; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Barendse RS; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Dubois JMN; Department of Hematology, Cancer Care Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., van Oers MHJ; Department of Hematology, Cancer Care Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Geisler CH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Kater AP; Department of Hematology, Cancer Care Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Langerak AW; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands. m-d.levin@asz.nl.
Publikováno v:
Leukemia [Leukemia] 2023 Sep; Vol. 37 (9), pp. 1929-1932. Date of Electronic Publication: 2023 Jul 21.
Autor:
Hengeveld PJ; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Schilperoord-Vermeulen J; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., van der Klift MY; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Dubois JMN; Department of Hematology and Experimental Immunology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Kolijn PM; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Kavelaars FG; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Rijken M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Dobber JA; Department of Hematology and Experimental Immunology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Kersting S; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Kater AP; Department of Hematology and Experimental Immunology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Langerak AW; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands. m-d.levin@asz.nl.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Jul 04; Vol. 13 (1), pp. 102. Date of Electronic Publication: 2023 Jul 04.
Autor:
Hengeveld PJ; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Ertem YE; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Dubois JMN; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Mellink CHM; Department of Human Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., van der Kevie-Kersemaekers AM; Department of Human Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Evers LM; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Heezen K; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Kolijn PM; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Mook ORF; Department of Human Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Motazacker MM; Department of Human Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Nasserinejad K; HOVON Data Center, Dept. of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Kersting S; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kater AP; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Langerak AW; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands. m-d.levin@asz.nl.
Publikováno v:
Leukemia [Leukemia] 2022 Jul; Vol. 36 (7), pp. 1935-1938. Date of Electronic Publication: 2022 May 18.